Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

Group One winner Victor The Winner warmed up for Champions Day with a stylish trial win as the first batch of international ...

Hong Kong Students Pave the Future for Various Industries with AI After an 8-month innovation journey, with the record-breaking number of participating teams ...